Article
Chronic Lymphocytic Leukemia Highlights From ASH 2022
- Author:
- Nicholas R. Burwick, MD
Publish date: January 11, 2023
CLL treatments from ASH 2022 include pirtobrutinib in pretreated patients, zanubrutinib in relapsed/refractory disease, and frontline ibrutinib +...